R
Rebekah Shallcross
Researcher at University of Bristol
Publications - 14
Citations - 884
Rebekah Shallcross is an academic researcher from University of Bristol. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 8, co-authored 11 publications receiving 699 citations. Previous affiliations of Rebekah Shallcross include University of Manchester & University of Liverpool.
Papers
More filters
Journal ArticleDOI
The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs
Rebecca Bromley,George E. Mawer,Maria Briggs,Christopher P Cheyne,Jill Clayton-Smith,Marta García-Fiñana,Rachel Kneen,S. B. Lucas,Rebekah Shallcross,Gus A. Baker +9 more
TL;DR: An accumulation of evidence demonstrates that the risks associated with prenatal sodium VPA exposure include an increased prevalence of neurodevelopmental disorders, whether such disorders are discrete or represent the severe end of a continuum of altered neuro developmental functioning requires further investigation.
Journal ArticleDOI
IQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study
Gus A. Baker,Rebecca Bromley,Maria Briggs,Christopher P Cheyne,Morris J. Cohen,Marta García-Fiñana,Alison Gummery,Rachel Kneen,David W. Loring,George E. Mawer,Kimford J. Meador,Rebekah Shallcross,Rebekah Shallcross,Jill Clayton-Smith +13 more
TL;DR: For example, this article found that children exposed to high-dose valproate had an 8-fold increased need for educational intervention relative to control children (adjusted relative risk, 95% CI 8.0, 2.5-19.7; p p p = 0.04) and a 6-fold increase in educational intervention (95% CI 1.4-18.0; p =0.01).
Journal ArticleDOI
Child development following in utero exposure Levetiracetam vs sodium valproate
TL;DR: Children exposed to LEV in utero are not at an increased risk of delayed early cognitive development under the age of 24 months and LEV may be a preferable drug choice, where appropriate, for WWE prior to and of childbearing age.
Journal ArticleDOI
Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate
Rebecca Bromley,Rebecca Calderbank,Christopher P Cheyne,Claire Rooney,Penny Trayner,Jill Clayton-Smith,Marta García-Fiñana,B. Irwin,James I. Morrow,Rebekah Shallcross,Rebekah Shallcross,Gus A. Baker +11 more
TL;DR: Preconception counseling should include discussion of neurodevelopmental outcomes for specific treatments and their doses and women should be made aware of the limited nature of the evidence base for newer antiepileptic drugs.
Journal ArticleDOI
In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.
Rebekah Shallcross,Rebekah Shallcross,Rebecca Bromley,Christopher P Cheyne,Marta García-Fiñana,B. Irwin,Jim Morrow,Gus A. Baker +7 more
TL;DR: Children exposed to LEV in utero were superior in their language and motor development in comparison to children exposed to VPA, and this information should be used collaboratively between health care professionals and WWE when deciding on women's preferred choice of antiepileptic drug.